News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New York Biotechnology Association Selects PR Newswire As Exclusive Provider Of News And Information From Biotech Companies


10/19/2005 5:10:10 PM

NEW YORK, Feb. 26 /PRNewswire/ -- Biotechnology companies who rely on PR Newswire to distribute their up-to-the-minute full-text news developments to the media, financial community and general public, can now directly reach interested parties who regularly visit the New York Biotechnology Association's web site, http://www.nyba.org/, as the result of an exclusive agreement between the two organizations, it was announced today.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000306/PRNLOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/NYTH017 )

This agreement is in support of New York Biotechnology Association's new campaign, The Cures Start Here(TM). The campaign's focus is to boost awareness of New York State's biotechnology cluster and amplify all the good news coming out of the industry in New York. New York is one of the nation's leading biotechnology centers, and in a number of measures, New York State ranks among the top contributors to the industry's impressive success and progress.

With more than 260 member organizations, the New York Biotechnology Association is dedicated to the development and growth of the New York State based biotechnology related industries. The web site, http://www.nyba.org/, provides relevant information on New York's vibrant biotech industry, and links members and users with resources to assist in creating successful biotech ventures. PR Newswire's content is located under the "Daily Industry News" link accessible from the home page.

"The addition of PR Newswire's content will allow the many visitors to our website to stay abreast of the latest developments from leading biotech companies around the country," said Karin Duncker, Executive Director of NYBA. "This is an important tool to advancing the development of these companies and the industry itself in New York State."

"PR Newswire works with many of the leading biotechnology companies around the world," said Ken Dowell, Managing Director, Targeting Services, PR Newswire. "It is our commitment to get the best and most appropriate visibility for their important news and information."

PR Newswire enables biotech companies to communicate with their key audiences through specific industry newslines that reach media covering biotech related industries; through targeted distribution to biotech reporters through its media targeting database, OnlineMEDIAtlas, and through direct distribution to biotech reporters through PR Newswire for Journalists, its media-only web site.

"The additional distribution of this content to niche websites such as NYBA's, will place our biotech members' news and information directly into the hands of some of the most influential people in the biotech industry," Dowell concluded.

About The New York Biotechnology Association

NYBA is the collective voice of the biotechnology community in New York State, representing the industry to government, media, financial and biotechnology interests both within New York's borders and throughout the larger national and international biotechnology communities. NYBA's mission is two-fold: to aid and promote the growth of New York's biotech companies, and to help New York State realize its potential as a premier global center for the biotechnology industry. NYBA's membership comprises over 260 bioscience companies, world-class research institutions and related professional services. Through NYBA, biotechnology professionals are able to access the information, resources and assistance they need to make their ventures a success. In 2003, NYBA announced a new promotional campaign to boost awareness of New York State's biotechnology cluster under the motto: The Cures Start Here(TM). The campaign's goal is to amplify the success the State has had and continues to have in discovering major medical advances and growing a vibrant biotech industry. NYBA promotes cooperation among academia, industry and both new and established companies. NYBA maintains a network of specialists available to offer assistance with start-up ventures, and provides established companies with new opportunities for collaborations. Through its public outreach efforts, NYBA works with the media, community groups and economic development associations to educate the broader public about the benefits of biotechnology. For more information on NYBA programs and initiatives, visit our website at http://www.nyba.org/.

About PR Newswire Association LLC

Now in its 50th year, PR Newswire Association LLC (http://www.prnewswire.com/) provides electronic distribution, targeting, measurement, translation and broadcast services on behalf of some 40,000 customers worldwide who seek to reach the news media, the investment community and the general public with their up-to-the-minute, full-text news developments. Established in 1954, PR Newswire has offices in fourteen countries and routinely sends its customers' news to outlets in 135 countries and in 30 languages. Utilizing the latest in communications technology, PR Newswire content is considered a mainstay among news reporters, investors and private individuals. PR Newswire's leading brands include ProfNet(SM), eWatch(TM), Online MEDIAtlas(TM) and MultiVu(TM), a PR Newswire company. PR Newswire is a subsidiary of United Business Media plc of London.

Contact: Rachel Asche, Director of Public Relations, PR Newswire, 212.282.1929 or rachel.asche@prnewswire.com.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20000306/PRNLOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, +1-888-776-6555 or +1-212-782-2840/Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040226/NYTH017AP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.com/ New York Biotechnology Association; PR Newswire Association LLC

CONTACT: Rachel Asche, Director of Public Relations, PR Newswire,+1-212-282-1929, rachel.asche@prnewswire.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES